Full-Time

Director of Sales

Sports Medicine

Posted on 5/9/2026

Smith+Nephew

Smith+Nephew

10,001+ employees

Global medical devices for orthopedics

Compensation Overview

$125k - $150k/yr

+ Commission + Bonus

Denver, CO, USA

In Person

Weekly travel with sales reps for field visits; overnight travel as needed.

Category
Sales & Account Management (1)
Required Skills
Sales
Requirements
  • Bachelor’s degree or equivalent experience
  • Minimum 5 years of successful sales experience in the medical device industry
  • At least 5 years in a sales management role, ideally within medical devices, with a proven record of exceeding quotas
  • Experience managing large territories ($10M+ revenue) and leading teams of 12+ direct reports
  • Travel requirements: weekly travel with sales reps for a minimum of 1 field visit/week; will require travel and overnight stays as required to support customer needs and rep development
  • Credentialing process for healthcare facilities entry, which often includes COVID-19 vaccine management
  • Proven ability to leverage financing programs and resources to meet customer needs
  • Strong presentation and communication skills with the ability to build lasting customer relationships
Responsibilities
  • Attract, develop, train, retain, and manage sales talent to achieve sales revenue and gross profit in the region
  • Provide accurate and timely marketing information, analysis, recommendations and facilitate effective communication between sales representatives and Smith & Nephew Sports Medicine
  • Develop and execute an annual regional business plan with measurable KPIs and outcomes
  • Set and manage sales quotas, discount targets, demo inventory compliance, and capital placement programs
  • Monitor and adapt sales strategies based on market trends, competitor activity, and evolving business needs
  • Provide insightful reporting on organizational capacity, sales program performance, and field utilization
  • Recruit, onboard, and coach top-performing sales professionals to minimize territory vacancy (target: < 4 weeks)
  • Identify development and training opportunities to build a clinically and technically competent team
  • Establish clear sales objectives through Smith & Nephew’s performance management system and review results quarterly
  • Conduct weekly coaching sessions to align individual activities with sales goals
  • Assess team performance and support career development, identifying high-potential individuals for advancement
  • Travel as required to support customer needs and rep development
Desired Qualifications
  • Established network and industry contacts in the region is a strong plus

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Simplify Jobs

Simplify's Take

What believers are saying

  • Innovation drove over 60% of 2025 growth; products launched past five years deliver double-digit growth.
  • Free cash flow surged 52.5% to $840M, enabling $500M share buyback and strategic acquisitions.
  • Integrity Orthopaedics acquisition expands $875M rotator cuff repair market with proven clinical outcomes.

What critics are saying

  • Memphis manufacturing consolidation creates single-point-of-failure for orthopedics production in 12-24 months.
  • Integrity acquisition's $225M performance milestones depend on unproven Tendon Seam technology achieving adoption.
  • Chinese pricing reforms and US reimbursement headwinds compress margins simultaneously in 2026.

What makes Smith+Nephew unique

  • Tendon Seam rotator cuff technology addresses 500,000 annual US procedures with lower re-tear rates.
  • ALLEVYN COMPLETE CARE releases 100 times fewer bacteria than competing foam dressings.
  • RENASYS EDGE achieves 88% patient compliance with lightweight, modular negative pressure system.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Smith+Nephew who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Parental Leave

Fertility Treatment Support

Family Planning Benefits

Tuition Reimbursement

Wellness Program

Mental Health Support

Volunteer Time Off

Home Office Stipend

Phone/Internet Stipend

Discounted Stock Options

Health Savings Account/Flexible Spending Account

Employee Assistance Program

PTO/vacation?

Paid Sick Leave

Company News

Yahoo Finance
Mar 4th, 2026
Smith & Nephew reports $6.2B revenue with 5.3% growth and 53% jump in free cash flow

Smith & Nephew reported strong full-year 2025 results, with revenue of $6.2 billion representing 5.3% underlying growth and 6.1% reported growth. Fourth-quarter revenue reached $1.7 billion, growing 6.2% on an underlying basis. The medical device company achieved 160 basis points of margin expansion, with trading profit of $1.2 billion and adjusted earnings per share of $1.02, up 21%. Free cash flow increased 52.5% year-on-year to $840 million, enabling completion of a $500 million share buyback programme. Innovation drove over 60% of growth, with products launched in the past five years delivering double-digit growth across all business units. For 2026, the company expects 6% organic revenue growth and 8% trading profit growth to around $1.3 billion, though it faces headwinds from Chinese pricing reforms and US reimbursement changes.

Yahoo Finance
Feb 25th, 2026
Smith & Nephew signs exclusive US distribution deal with RMR Ortho for A'TOMIC Nitinol Fixation System

Smith+Nephew has signed an exclusive US distribution agreement with RMR Ortho to add the A'TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle and Hand & Wrist portfolio. The partnership enables Smith+Nephew to expand its participation in high-frequency fracture and arthrodesis procedures whilst utilising its existing Extremities and Trauma sales channel. The dynamic compression fixation solution complements the company's current technologies. Scott Gunn, Vice President of US Marketing at Smith+Nephew, said the collaboration reflects the company's disciplined approach to portfolio expansion and continued focus on driving sustainable growth.

Investegate Ltd
Jan 12th, 2026
Smith+Nephew acquires Integrity Orthopaedics for $225M plus $225M in performance payments

Smith+Nephew has acquired Integrity Orthopaedics for an initial $225 million cash payment, plus up to $225 million in performance-based payments over five years. The deal strengthens Smith+Nephew's sports medicine portfolio with the Tendon Seam rotator cuff repair technology. Founded in 2020, Integrity Orthopaedics developed the innovative system to address high failure rates in traditional rotator cuff repairs. The technology uses patented micro-anchors and continuous suture designed to deliver stronger repairs and lower re-tear rates. Early clinical results show reduced pain and shorter recovery times. The rotator cuff repair market performs approximately 500,000 procedures annually in the US, valued at $875 million. The acquisition, expected to close by end of January 2026, will be financed from existing cash facilities and is expected to be accretive to trading profit margin by 2028.

Startupticker.ch
Jun 2nd, 2025
Smith & Nephew acquires Atracsys to expand its digital surgery ecosystem

Download the Swiss reference publication on investments, investors and exits in our assets section.

The Manila Times
Mar 11th, 2025
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for robotics, knees, hips, and shoulders at AAOS 2025.